Insider Transactions in Q1 2023 at Phathom Pharmaceuticals, Inc. (PHAT)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Molly Henderson CFO and CBO |
SELL
Open market or private sale
|
Direct |
2,032
-2.6%
|
$16,256
$8.53 P/Share
|
|
Mar 01
2023
|
Terrie Curran President and Chief Executive |
SELL
Open market or private sale
|
Direct |
1,436
-0.81%
|
$11,488
$8.54 P/Share
|
|
Feb 13
2023
|
Asit Parikh |
BUY
Open market or private purchase
|
Direct |
5,000
+18.18%
|
$35,000
$7.73 P/Share
|
|
Jan 20
2023
|
Terrie Curran President and Chief Executive |
SELL
Open market or private sale
|
Direct |
5,821
-3.19%
|
$46,568
$8.2 P/Share
|
|
Jan 19
2023
|
Terrie Curran President and Chief Executive |
BUY
Grant, award, or other acquisition
|
Direct |
97,500
+34.81%
|
-
|
|
Jan 19
2023
|
Azmi Nabulsi Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+33.44%
|
-
|
|
Jan 19
2023
|
Molly Henderson CFO and CBO |
BUY
Grant, award, or other acquisition
|
Direct |
33,000
+29.72%
|
-
|
|
Jan 12
2023
|
Asit Parikh |
BUY
Open market or private purchase
|
Direct |
5,000
+22.22%
|
$35,000
$7.0 P/Share
|